A61K 38/1808
Epidermal growth factor [egf] urogastrone
Official title: {Epidermal growth factor [EGF] urogastrone}
A61K38/1808 (Epidermal growth factor [egf] urogastrone) appears on 386 US grants and 711 published applications in this corpus.
Search patents in A61K- Granted patents
- 386
- Published applications
- 711
- Assignees
- 424
- Inventors
- 1,307
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1988 | 4 | 0 |
| 1989 | 2 | 0 |
| 1990 | 1 | 0 |
| 1991 | 11 | 0 |
| 1992 | 3 | 0 |
| 1993 | 5 | 0 |
| 1994 | 4 | 0 |
| 1995 | 6 | 0 |
| 1996 | 3 | 0 |
| 1997 | 12 | 0 |
| 1998 | 5 | 0 |
| 1999 | 5 | 0 |
| 2000 | 3 | 0 |
| 2001 | 9 | 4 |
| 2002 | 4 | 10 |
| 2003 | 5 | 15 |
| 2004 | 1 | 17 |
| 2005 | 1 | 20 |
| 2006 | 8 | 25 |
| 2007 | 5 | 25 |
| 2008 | 8 | 28 |
| 2009 | 11 | 21 |
| 2010 | 10 | 26 |
| 2011 | 1 | 35 |
| 2012 | 18 | 19 |
| 2013 | 8 | 45 |
| 2014 | 21 | 41 |
| 2015 | 27 | 42 |
| 2016 | 23 | 31 |
| 2017 | 24 | 38 |
| 2018 | 15 | 35 |
| 2019 | 29 | 35 |
| 2020 | 20 | 40 |
| 2021 | 19 | 37 |
| 2022 | 16 | 39 |
| 2023 | 8 | 26 |
| 2024 | 15 | 22 |
| 2025 | 8 | 25 |
| 2026 | 8 | 10 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Hyaluronic acid derivative and use thereof29 Sep 2026US 12,746,306 B2Amtixbio Co., Ltd.
- Gla domains as therapeutic agents14 Jul 2026US 12,678,481 B2Gladiator Biosciences, Inc.
- Mucoadhesive microgel compositions and methods for using the same2 Jun 2026US 12,642,839 B2Centre National De La Recherche Scientifique
- Methods and compositions for use of growth factor antibodies in combination with non-tyrosine targeting kinase inhibitors26 May 2026US 12,636,376 B2
- Allogeneic human plasma and platelet derived products and uses thereof17 Mar 2026US 12,576,109 B2Consano Bio, Inc.
- Neurotrauma treatment1 Oct 2026US 2026/0295016 A1Ecole Polytechnique Federale De Lausanne (Epfl)
- Treg therapy10 Sep 2026US 2026/0263556 A1Quell Therapeutics Limited
- Drug for repairing refractory wound3 Sep 2026US 2026/0256878 A1Shanghai Celleaf Biotechnology Co., Ltd.
- Methods and compositions for the treatment of epidermolysis bullosa2 Jul 2026US 2026/0183238 A1University of Miami
- Allogeneic human plasma and platelet derived products and uses thereof2 Jul 2026US 2026/0183336 A1Consano Bio, Inc.
Most cited
By later US patents
- Supplemented and unsupplemented tissue sealants, methods of their production and use441US 6,197,325 B1American National Red Cross · 2001
- Method of preparing a tissue sealant-treated biomedical material177US 6,559,119 B1American National Red Cross · 2003
- Treatment of retinitis pigmentosa with human umbilical cord cells175US 7,413,734 B2Ethicon, Inc. · 2008
- Localized intravascular delivery of growth factors for promotion of angiogenesis169US 5,941,868 ABeth Israel Deaconess Medical Center, Inc. · 1999
- Hyaluronics acid fractions, methods for the preparation thereof, and pharmaceutical compositions containing same140US 5,166,331 AFidia S.p.A. · 1992